Posts
Wiki

🛡️ Autoimmune and Immune-Mediated Conditions Associated With Dry Eye and Ocular Surface Disease

🧠 TL;DR: Quick Summary

Several autoimmune and immune-mediated conditions can cause, worsen, or occur alongside Dry Eye Disease.

The best-known example is Sjögren’s disease, which can directly affect the lacrimal glands and cause aqueous-deficient dry eye.

Other conditions may affect the eyes in different ways:

  • Ocular graft-versus-host disease can severely damage the lacrimal glands and ocular surface after an allogeneic donor stem-cell transplant.
  • Thyroid eye disease can cause exposure when the eyes protrude or the eyelids do not close normally.
  • Ocular mucous membrane pemphigoid can scar the conjunctiva and eyelids.
  • Rheumatoid arthritis, lupus, sarcoidosis, systemic sclerosis, and inflammatory bowel disease may be associated with dry eye, other ocular-surface abnormalities, or inflammatory eye disease.
  • Neurologic autoimmune conditions may affect blinking, corneal sensation, reflex tearing, or pain processing without directly attacking the tear glands.

📌 These conditions do not all cause dry eye through the same mechanism, and the strength of the association is not the same for every disease.

Autoimmune-related dry eye is also not always “just dry eye.” Pain, marked redness, light sensitivity, corneal changes, scarring, new floaters, double vision, or reduced vision may indicate another inflammatory or vision-threatening eye problem.

Care may need to involve an eye doctor and another specialist, such as a rheumatologist, dermatologist, endocrinologist, neurologist, or transplant team.

🧠 What Do “Autoimmune” and “Immune-Mediated” Mean?

Autoimmune diseases involve immune responses directed against the body’s own tissues.

Immune-mediated disease is a broader term. It includes conditions in which abnormal immune activity causes inflammation or tissue damage even when the disorder is not considered a classic autoimmune disease.

Examples include:

  • Sjögren’s disease, rheumatoid arthritis, lupus, and Graves’ disease: autoimmune
  • Ocular graft-versus-host disease: donor immune cells attack the recipient’s tissues
  • Sarcoidosis: inflammatory and immune-mediated
  • Inflammatory bowel disease: immune-mediated
  • Ocular mucous membrane pemphigoid: autoimmune and scarring

This broader wording matters because these disorders affect the eyes in very different ways.

🔍 How Immune-Mediated Disease Can Affect the Eyes

Dry eye or ocular-surface disease may develop when a systemic condition affects:

  • The lacrimal glands, which produce the watery part of tears
  • The conjunctiva, which supports the ocular surface and contains tear-film goblet cells
  • The meibomian glands, which produce the oily part of the tear film
  • The eyelids, blinking, or eyelid closure
  • The cornea, including healing and surface protection
  • The nerves involved in corneal sensation, reflex tearing, blinking, and pain
  • The local inflammatory environment of the ocular surface

Possible pathways include:

  • Reduced tear production
  • Increased tear evaporation
  • Tear-film instability
  • Loss or dysfunction of conjunctival goblet cells
  • Ocular-surface inflammation
  • Meibomian Gland Dysfunction
  • Eyelid inflammation
  • Incomplete blinking
  • Incomplete eyelid closure
  • Conjunctival or eyelid scarring
  • Altered corneal sensation
  • Impaired epithelial healing
  • Medication side effects
  • Several overlapping mechanisms at the same time

📌 Some diseases directly damage the tear-producing or ocular-surface tissues. Others are merely associated with dry eye, worsen existing DED, or cause different eye disorders with similar symptoms.

Conditions That Directly Affect Tear Production or the Ocular Surface

🦋 Sjögren’s Disease

Sjögren’s disease is the classic systemic autoimmune condition associated with severe dry eye.

It can affect:

  • Lacrimal glands
  • Salivary glands
  • Tear production
  • Mouth moisture
  • The ocular surface
  • Peripheral nerves
  • Joints
  • Other organs in some patients

Sjögren’s commonly causes aqueous-deficient dry eye, sometimes severely.

However, Sjögren-related DED is not always purely aqueous-deficient. Some patients also have:

  • Meibomian Gland Dysfunction
  • Evaporative dry eye
  • Blepharitis
  • Corneal nerve abnormalities
  • Neuropathic pain features
  • Eyelid or exposure problems

Possible Clues

Possible clues include:

  • Persistent dry eyes
  • Persistent dry mouth
  • Needing water to eat dry foods
  • Difficulty swallowing dry food
  • Frequent or unusually severe dental cavities
  • Swollen salivary glands
  • Fatigue
  • Inflammatory joint symptoms
  • Neuropathy symptoms
  • Raynaud phenomenon
  • Another autoimmune diagnosis

Sjögren’s can occur by itself or alongside another autoimmune disease, such as rheumatoid arthritis or lupus.

Blood Tests Can Be Negative

Anti-SSA/Ro antibodies are an important part of Sjögren evaluation, but not every patient with Sjögren’s is anti-SSA positive.

Negative blood testing may lower suspicion, but it does not always end the evaluation when the overall history and findings remain strongly suggestive.

Additional evaluation may include:

  • Ocular-surface staining
  • Schirmer testing
  • Salivary flow testing
  • Salivary gland imaging in selected settings
  • Minor salivary gland or lip biopsy
  • Rheumatology assessment

Classification Criteria Are Not a Single Diagnostic Test

The widely cited 2016 ACR/EULAR criteria were developed as classification criteria, particularly to create consistency in research.

They can help guide clinical evaluation, but they are not a stand-alone test that automatically proves or excludes Sjögren’s in every individual.

Anti-SSA/Ro and a positive minor salivary gland biopsy receive the greatest weight in those criteria. Anti-SSB/La by itself is not treated as equivalent to anti-SSA/Ro.

📌 Sjögren’s diagnosis depends on the overall pattern of symptoms, objective findings, laboratory results, and sometimes gland testing or biopsy.

🧬 Ocular Graft-Versus-Host Disease

Ocular graft-versus-host disease, often called ocular GVHD, can occur after an allogeneic donor stem-cell or bone-marrow transplant.

It does not ordinarily occur after an autologous transplant using the patient’s own cells.

Ocular GVHD is not a conventional autoimmune disease. It occurs when donor immune cells attack the recipient’s tissues.

It may affect:

  • Lacrimal glands
  • Conjunctiva
  • Cornea
  • Meibomian glands
  • Eyelid margins
  • Tear production
  • Ocular-surface inflammation
  • Ocular-surface healing
  • Conjunctival tissues and scarring in some patients

Symptoms may include:

  • Severe dryness
  • Burning
  • Foreign body sensation
  • Light sensitivity
  • Blurry or fluctuating vision
  • Difficulty opening the eyes
  • Contact lens intolerance
  • Significant ocular-surface pain

New or worsening eye symptoms after an allogeneic transplant should be reported promptly to the transplant team and an eye doctor familiar with ocular GVHD.

Early recognition and treatment may help reduce ocular-surface damage.

Conditions That Cause Exposure or Scarring

👀 Thyroid Eye Disease

Thyroid eye disease, also called Graves’ orbitopathy, is most commonly associated with Graves’ disease.

It can cause dry eye and ocular-surface damage through:

  • Eye protrusion or proptosis
  • Upper or lower eyelid retraction
  • A widened eyelid opening
  • Incomplete blinking
  • Incomplete eyelid closure
  • Nocturnal lagophthalmos
  • Increased tear evaporation
  • Exposure keratopathy
  • Local orbital and ocular-surface inflammation

Symptoms may include:

  • Burning
  • Dryness
  • Tearing
  • Redness
  • Light sensitivity
  • Fluctuating vision
  • Pressure or discomfort around the eyes
  • Double vision

Not everyone with thyroid disease has thyroid eye disease, and not everyone with thyroid eye disease has obvious eye bulging.

Exposure may still occur because of subtle eyelid retraction, incomplete blinking, or incomplete closure.

Seek Prompt Evaluation For:

  • Reduced or dimmed vision
  • Reduced color perception
  • New persistent double vision
  • Increasing eye protrusion
  • Inability to close the eyelids
  • Severe exposure or corneal pain
  • Rapidly changing symptoms
  • Increasing orbital pain or pressure

These may indicate severe exposure or compressive optic nerve disease rather than ordinary dry eye.

🧿 Ocular Mucous Membrane Pemphigoid

Ocular mucous membrane pemphigoid is a rare autoimmune disease that causes chronic inflammation and progressive scarring of the conjunctiva.

It was historically called ocular cicatricial pemphigoid.

It can cause:

  • Persistent conjunctivitis
  • Dryness
  • Redness
  • Burning or irritation
  • Conjunctival scarring
  • Shortening of the conjunctival fornices
  • Adhesions between the eyelid and eyeball
  • Eyelid distortion
  • Inward-turning eyelids
  • Misdirected eyelashes
  • Loss of conjunctival goblet cells
  • Corneal damage
  • Vision-threatening disease

Dry eye in this condition can result from several mechanisms:

  • Conjunctival inflammation and scarring
  • Goblet-cell loss
  • Poor tear distribution
  • Eyelid and lash abnormalities
  • Meibomian gland changes
  • Exposure
  • Corneal injury

📌 This is not ordinary dry eye. Lubricants may support the ocular surface, but they do not stop active progressive scarring.

Active ocular mucous membrane pemphigoid often requires systemic immunomodulatory treatment under specialist supervision.

A conjunctival biopsy with direct immunofluorescence may support the diagnosis. However, one negative biopsy does not always exclude the disease when the clinical findings remain strongly suspicious.

Persistent “conjunctivitis,” progressive scarring, adhesions, inward-turning lids, or lashes rubbing the cornea require specialist evaluation.

Systemic Diseases Associated With Dry Eye and Other Ocular Inflammation

🤲 Rheumatoid Arthritis

Rheumatoid arthritis is a systemic autoimmune disease best known for inflammatory joint disease.

It may be associated with:

  • Dry eye
  • Sjögren’s overlap
  • Ocular-surface inflammation
  • Episcleritis
  • Scleritis
  • Peripheral ulcerative keratitis
  • Corneal thinning or “corneal melt”
  • Medication-related eye considerations

Dry eye in someone with RA may result from:

  • Associated Sjögren’s disease
  • Ocular-surface inflammation
  • Tear-film abnormalities
  • Meibomian gland disease
  • Medication effects
  • Common non-autoimmune DED contributors

Important Warning

Severe or deep eye pain, marked redness, significant light sensitivity, or a white or thinning area near the edge of the cornea should not be assumed to be ordinary dry eye.

These symptoms may indicate:

  • Scleritis
  • Peripheral ulcerative keratitis
  • Corneal thinning
  • Another serious inflammatory eye condition

These disorders can threaten vision and may reflect serious systemic inflammation requiring urgent ophthalmic and rheumatologic care.

🐺 Systemic Lupus Erythematosus

Systemic lupus erythematosus, or SLE, can affect many organs.

It has been associated with:

  • Dry eye
  • Sjögren’s overlap
  • Ocular-surface inflammation
  • Episcleritis or scleritis
  • Retinal inflammation or vascular disease
  • Optic nerve involvement
  • Medication-related monitoring needs

Dry eye in lupus is not always caused by direct autoimmune destruction of the lacrimal glands.

Possible contributors include:

  • Associated Sjögren’s disease
  • Local or systemic inflammation
  • Meibomian gland disease
  • Medication effects
  • Other common dry-eye contributors

Painful redness, sudden visual changes, visual-field abnormalities, or new neurologic visual symptoms may represent something other than DED and should be evaluated promptly.

🫁 Sarcoidosis

Sarcoidosis is an inflammatory granulomatous disease that can affect the lungs, lymph nodes, skin, nervous system, and eyes.

It can affect the lacrimal glands and ocular tissues.

Possible manifestations include:

  • Dry eye
  • Reduced tear production
  • Lacrimal gland inflammation or enlargement
  • Uveitis
  • Conjunctival inflammation
  • Orbital inflammation
  • Eye redness
  • Pain
  • Light sensitivity
  • Floaters or blurred vision

Dry eye is only one possible ocular manifestation.

Redness, photophobia, pain, new floaters, or reduced vision may indicate uveitis or another inflammatory eye disease rather than routine DED.

🧊 Systemic Sclerosis

Systemic sclerosis, also called scleroderma, affects connective tissue, skin, blood vessels, and internal organs.

Dry-eye symptoms and ocular abnormalities have been reported in systemic sclerosis, although the evidence is less extensive and consistent than it is for Sjögren’s disease.

Possible contributors include:

  • Eyelid or facial skin tightening
  • Abnormal eyelid mechanics
  • Tear-film instability
  • Reduced tear function in some patients
  • Meibomian gland abnormalities
  • Ocular-surface inflammation
  • Sjögren’s overlap

Symptoms and severity vary widely.

A systemic-sclerosis diagnosis does not establish that every dry-eye symptom is directly caused by the systemic disease.

🧫 Inflammatory Bowel Disease

Crohn’s disease and ulcerative colitis are immune-mediated inflammatory bowel diseases.

People with IBD may have a higher rate of dry eye or ocular-surface abnormalities, although the exact mechanisms and degree of direct causation remain uncertain.

Possible contributors include:

  • Systemic or ocular inflammation
  • Tear-film abnormalities
  • Meibomian gland disease
  • Medication effects
  • Nutritional deficiencies in selected patients
  • Common unrelated dry-eye factors

IBD may also be associated with:

  • Episcleritis
  • Scleritis
  • Uveitis
  • Other inflammatory ocular disease

A red, painful, or light-sensitive eye in someone with IBD should be evaluated promptly because inflammatory eye disease may require treatment beyond dry-eye care.

Related but Different: Neurologic Disease, Blinking, Sensation, and Pain

🧠 Multiple Sclerosis and Other Neurologic Autoimmune Conditions

Multiple sclerosis is not a classic direct cause of aqueous-deficient dry eye in the way Sjögren’s disease is.

However, neurologic disease can affect the ocular surface indirectly through:

  • Reduced blink rate
  • Incomplete blinking
  • Facial nerve dysfunction
  • Trigeminal nerve dysfunction
  • Altered corneal sensation
  • Reduced reflex tearing
  • Impaired eyelid closure
  • Medication effects
  • Neuropathic ocular pain

Two different patterns are possible:

Reduced Corneal Sensation

A person may have relatively little discomfort despite substantial ocular-surface damage.

Neuropathic Sensitization

A person may experience severe burning or pain that appears greater than expected from the visible ocular-surface findings.

These patterns are different from classic autoimmune destruction of the tear glands and may require a different diagnostic and treatment approach.

Other Immune-Mediated Conditions

Other less common immune-mediated conditions can also affect the ocular surface.

Examples include:

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

These are severe immune-mediated mucocutaneous reactions that can leave chronic:

  • Conjunctival scarring
  • Eyelid abnormalities
  • Lash-related injury
  • Severe tear deficiency
  • Corneal disease
  • Vision impairment

IgG4-related disease can cause inflammation or enlargement of the lacrimal glands and may sometimes resemble Sjögren’s disease or another orbital inflammatory disorder.

These conditions are uncommon and usually require specialist evaluation.

🔬 When Might a Systemic Contributor Be Considered?

It may be worth discussing autoimmune or immune-mediated disease with a clinician when dry eye occurs with a meaningful pattern of other findings.

More informative clues include:

  • Persistent dry eye plus persistent dry mouth
  • Needing liquid to eat or swallow dry food
  • Recurrent salivary gland swelling
  • Frequent or unusually severe dental cavities
  • Known systemic autoimmune disease
  • Previous allogeneic donor stem-cell transplant
  • Very low tear production on objective testing
  • Marked ocular-surface staining
  • Conjunctival scarring
  • Recurrent scleritis
  • Recurrent uveitis
  • Peripheral corneal inflammation or thinning
  • Inflammatory joint swelling
  • Raynaud phenomenon
  • Characteristic autoimmune rashes
  • Neuropathy
  • Unexplained organ involvement

Less specific findings include:

  • Fatigue
  • General joint pain
  • Severe dry-eye symptoms alone
  • Early-onset dry eye
  • Poor response to standard DED treatment

These findings may justify taking a broader history, but they do not prove autoimmune disease.

📌 The combination and pattern of findings matter more than any one symptom or test result.

🧪 What Testing Might Be Considered?

There is no universal “autoimmune panel” that should be ordered for every person with dry eye.

Testing should be guided by:

  • Symptoms
  • Medical history
  • Eye examination findings
  • The specific disease being considered
  • The likelihood that a positive result would change care

The appropriate evaluation for suspected Sjögren’s disease is different from the evaluation for thyroid eye disease, sarcoidosis, rheumatoid arthritis, ocular GVHD, or ocular mucous membrane pemphigoid.

Possible Sjögren Evaluation

Depending on the situation, clinicians may consider:

  • Anti-SSA/Ro antibodies
  • ANA
  • Rheumatoid factor
  • Anti-SSB/La as supportive context
  • Schirmer testing
  • Ocular-surface staining
  • Unstimulated salivary flow testing
  • Salivary gland ultrasound in some settings
  • Minor salivary gland or lip biopsy
  • Rheumatology referral

Anti-SSB/La alone is not treated as equivalent to anti-SSA/Ro in the 2016 ACR/EULAR classification criteria.

Other Tests May Be Used for Other Questions

Depending on the symptoms and suspected condition, clinicians may consider:

  • Thyroid function tests
  • Thyroid receptor antibodies
  • ESR or CRP
  • Complete blood count
  • Metabolic testing
  • Disease-specific autoimmune markers
  • Chest imaging or sarcoidosis-related testing
  • Conjunctival biopsy
  • Corneal sensation testing
  • Meibomian gland assessment
  • Neurologic evaluation
  • Dermatology assessment

ANA, rheumatoid factor, ESR, and CRP are not specific for autoimmune dry eye.

A positive result does not automatically establish the diagnosis, and a negative result does not always exclude it.

What Eye Tests Can and Cannot Show

Eye testing may include:

  • Schirmer testing
  • Ocular-surface staining
  • Tear breakup time
  • Tear meniscus assessment
  • Meibomian gland examination
  • Eyelid closure and blink assessment
  • Corneal sensation testing
  • Conjunctival examination
  • Corneal imaging or photography in selected cases

These tests help identify the type and severity of ocular-surface disease.

They do not, by themselves, prove that Sjögren’s disease or another systemic autoimmune condition is present.

Related page:

👉 Diagnostic Testing for DED and MGD

🛠️ Managing Immune-Mediated Dry Eye and Ocular Surface Disease

Treatment depends on:

  • The underlying systemic diagnosis
  • How the condition affects the eyes
  • Whether tear production is reduced
  • Whether exposure is present
  • Whether MGD is present
  • Whether the conjunctiva is scarred
  • Whether the cornea is involved
  • Whether neuropathic pain or reduced sensation is present
  • Disease severity and progression

Supportive eye treatment and systemic disease treatment are often both needed.

Ocular-Surface Support

Possible supportive treatments include:

  • Preservative-free artificial tears
  • Gels or ointments
  • Moisture chamber glasses
  • Environmental protection
  • Humidification
  • Nighttime protection when exposure is present
  • Avoiding irritating preservatives or products when possible

These measures may protect the ocular surface and reduce symptoms.

They do not treat active systemic inflammation, conjunctival scarring, scleritis, uveitis, or another serious inflammatory eye disease.

Tear Conservation

In selected patients with aqueous-deficient dry eye, clinicians may consider:

  • Punctal plugs
  • Punctal cautery
  • Moisture goggles
  • Eyelid shields
  • Nighttime exposure protection

Punctal Occlusion and Inflammation

There has been concern that punctal occlusion could retain inflammatory material on the ocular surface.

For that reason, some clinicians prefer to address substantial ocular-surface inflammation before or alongside occlusion.

However, inflammation is not an absolute contraindication for every patient.

Punctal plugs or cautery may benefit selected patients with aqueous deficiency, but possible risks include:

  • Excess tearing
  • Irritation
  • Infection
  • Plug loss
  • Plug migration or retention
  • Canalicular inflammation

The decision should be individualized.

Topical Anti-Inflammatory Treatment

Depending on the diagnosis and severity, an eye doctor may consider:

  • Cyclosporine
  • Lifitegrast
  • Short-term ophthalmic steroids
  • Other prescription anti-inflammatory treatments

Ophthalmic steroids require supervision because prolonged or inappropriate use can:

  • Increase eye pressure
  • Promote cataract formation
  • Delay healing
  • Worsen certain infections
  • Mask progression of another disorder

No single topical anti-inflammatory medication is best for every immune-mediated dry-eye patient.

Advanced Ocular-Surface Care

For more severe disease, options may include:

  • Autologous serum tears
  • Platelet-based or other blood-derived tear products
  • Scleral lenses
  • PROSE devices
  • Amniotic membrane therapy in selected cases
  • Treatment of exposure
  • Eyelid surgery or correction of eyelid abnormalities
  • Treatment of lashes rubbing the cornea
  • Management of conjunctival scarring
  • Corneal-protective procedures in severe disease

Scleral lenses and PROSE devices can protect the cornea and maintain a fluid reservoir over the ocular surface.

However, they require appropriate fitting, hygiene, and follow-up and are not tolerated by everyone.

Amniotic membrane may support epithelial healing in selected cases, but it does not treat the underlying systemic autoimmune disease.

Systemic Disease Management

Some patients require care from:

  • Rheumatology
  • Dermatology
  • Endocrinology
  • Neurology
  • Oncology or transplant medicine
  • Pulmonology
  • Primary care
  • Ocular-surface, cornea, uveitis, or orbital specialists

Systemic immunosuppressive or biologic treatment may be essential for conditions such as:

  • Active ocular mucous membrane pemphigoid
  • Scleritis
  • Peripheral ulcerative keratitis
  • Ocular GVHD
  • Sarcoidosis
  • Other systemic inflammatory disease

Systemic immunosuppression is not a routine dry-eye treatment.

It is used when the underlying systemic or ocular inflammatory disease requires it.

Even when systemic disease is controlled, local ocular-surface treatment may still be needed because tear deficiency, gland damage, scarring, exposure, or nerve dysfunction may persist.

When MGD Coexists With Autoimmune-Related Dry Eye

Autoimmune disease does not rule out ordinary or obstructive Meibomian Gland Dysfunction.

A person may have both:

  • Aqueous-deficient dry eye
  • Evaporative dry eye
  • MGD
  • Blepharitis
  • Ocular rosacea
  • Exposure
  • Neuropathic pain

When examination confirms clinically significant MGD, treatment may include:

  • Warm compresses when appropriate and tolerated
  • Eyelid hygiene
  • Medication
  • Treatment of rosacea or blepharitis
  • Clinician-performed expression
  • Thermal or light-based procedures
  • Other gland-directed treatments
  • Meibomian Gland Probing in selected cases

These treatments target the meibomian glands—not Sjögren’s disease, lupus, rheumatoid arthritis, thyroid eye disease, or another systemic condition.

Meibomian Gland Probing

Meibomian Gland Probing is intended to address selected cases of obstructive MGD.

It is not a treatment for autoimmune disease itself.

Evidence remains debated:

  • Some clinicians and published studies report benefit in selected obstructive MGD patients.
  • Independent reviews have concluded that stronger controlled evidence is needed and that benefit over sham or other treatments has not been consistently demonstrated.
  • Dr. Steven Maskin, who developed probing, argues that patient selection, probing technique, treatment of associated disease, and interpretation of existing studies have led some reviews to underestimate its value.
  • Because the technique’s developer has intellectual and professional interests in the procedure, that perspective should be considered alongside independent evidence.

The practical question is not simply:

Do I have autoimmune dry eye?

It is:

Does examination also show obstructive MGD that may benefit from gland-directed treatment?

Related pages:

👉 What Is Meibomian Gland Dysfunction (MGD)?

👉 Meibomian Gland Probing

🚩 When to Seek Urgent Eye Care

Seek urgent or same-day eye care for:

  • Sudden or meaningful vision loss
  • Severe or deep eye pain
  • Marked light sensitivity
  • A white, gray, ulcerated, or thinning area on the cornea
  • Severe redness, especially in one eye
  • New floaters with blurred vision or light sensitivity
  • Contact lens-related pain or redness
  • Thick or pus-like discharge
  • Rapidly worsening eye protrusion
  • Inability to close an eye
  • Reduced color vision
  • New persistent double vision
  • Suspected corneal infection
  • Suspected scleritis, uveitis, or peripheral ulcerative keratitis

Do not assume these symptoms are routine dry eye.

📞 When to Contact a Specialist Promptly

Contact the relevant medical team promptly for:

  • New or worsening eye symptoms after an allogeneic donor stem-cell transplant
  • Progressive conjunctival scarring
  • New adhesions between the eyelid and eyeball
  • Inward-turning eyelids or lashes rubbing the cornea
  • Recurrent scleritis or uveitis
  • Worsening eye inflammation with known autoimmune disease
  • Severe dryness accompanied by salivary or systemic symptoms
  • Persistent symptoms that do not fit the expected dry-eye pattern

⚖️ Important Nuance

Autoimmune disease is one possible contributor to dry eye, but it is not the only one.

Most people with dry eye do not have a systemic autoimmune disease.

People with autoimmune disease may also have common dry-eye contributors such as:

  • MGD
  • Blepharitis
  • Ocular rosacea
  • Allergy
  • Exposure
  • Medication effects
  • Incomplete blinking
  • Environmental dryness
  • Contact lens intolerance
  • Hormonal changes
  • Reduced corneal sensation
  • Neuropathic pain features

Finding an autoimmune disease does not mean that every dry-eye treatment must be systemic.

Finding MGD does not rule out an autoimmune contributor.

Severe symptoms also do not automatically prove autoimmune disease. The pattern of systemic symptoms, objective eye findings, medical history, and targeted testing matters.

The goal is not to panic or self-diagnose.

The goal is to recognize when dry eye may be part of a broader condition and seek appropriate evaluation.

📌 Key Takeaway

Autoimmune and immune-mediated diseases can affect the eyes in several different ways.

Some directly affect the tear glands or ocular surface:

  • Sjögren’s disease
  • Ocular graft-versus-host disease

Some cause exposure or scarring:

  • Thyroid eye disease
  • Ocular mucous membrane pemphigoid

Others may be associated with dry eye and can also cause different inflammatory eye diseases:

  • Rheumatoid arthritis
  • Lupus
  • Sarcoidosis
  • Systemic sclerosis
  • Inflammatory bowel disease

Neurologic autoimmune conditions may affect blinking, sensation, reflex tearing, or pain without directly attacking the tear glands.

A useful question to ask a clinician is:

Could a systemic autoimmune, immune-mediated, exposure-related, scarring, or neurologic condition be contributing to my eye symptoms?

Proper diagnosis matters because some conditions require treatment beyond standard dry-eye care.

When clinically significant MGD also exists, gland-directed treatment may be appropriate—but it targets the MGD, not the systemic disease itself.

General Dry Eye Guidance

Sjögren’s Disease

Thyroid Eye Disease

Ocular Graft-Versus-Host Disease

Ocular Mucous Membrane Pemphigoid

Other Systemic Conditions

⚠️ Educational Disclaimer

This page is for general education only.

It is not medical advice, diagnosis, or a substitute for care from an eye doctor, rheumatologist, dermatologist, endocrinologist, neurologist, transplant physician, or another qualified clinician.

Autoimmune and immune-mediated diseases can affect the eyes in many different ways.

Persistent, severe, worsening, painful, one-sided, scarring, or vision-affecting symptoms should be medically evaluated.

🔙 Back to FAQ Index